Skip to main content

Table 1 Demographic data and clinical features of patients with Takayasu’s arteritis

From: Using the co-expression network of T cell-activation-related genes to assess the disease activity in Takayasu’s arteritis patients

 

Active (n = 11)

Inactive (n = 9)

P value

Age (year)

39.36 ± 7.89

39.44 ± 11.24

0.82

Gender (male/female)

1/10

0/9

0.35

Disease duration (month)

118.0 (13.0, 200.0)

35.56±26.66

0.10

ESR (mm/h)

16.82 ± 11.34

11.89 ± 4.88

0.33

hs-CRP (mg/L)

7.13±7.31

0.84 (0.26, 1.93)

0.02

Interleukin 6 (pg/mL)

4.27±2.65

2 (2.00, 2.70)

0.10

TNF-α (pg/mL)

6.85(5.50,8.38)

6.60 ± 2.24

0.66

Corticosteroid

Used/non-used

10/1

8/1

0.88

Dose (mg/d)a

10 (10, 40)

10 (6.25, 29.5)

0.37

  1. ESR erythrocyte sedimentation rate, hs-CRP hypersensitive C reactive protein, TNF-α tumor necrosis factor-α
  2. aCorticosteroid dose had been converted into the dose of prednisone
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us